At first glance this was huge news with chemical implications: $300 billion would be an extraordinary investment for a refinery, many times more than was put into China’s giant Zhejiang Petroleum and ...
IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save lives ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver ...
Image of a HER2-positive hybrid cell cluster stained with nanobodies. Credit: Debjani Pal/ORNL, U.S. Dept. of Energy ...
A 4th dose of the bivalent or monovalent Omicron BA.1-adapted BNT162b2 vaccine elicits robust neutralizing responses in adults aged 18 to 55.
Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive extreme conditions. After scanning huge genetic databases, researchers found ...
Morning Overview on MSN
Universal vaccine research advances, but a broad shot is still years away
The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...
Researchers at Stanford University have developed a nasal spray that offers months of protection against Covid-19 and hospital germs in laboratory tests.
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results